Azelex can be combined with a retinoid, but both products may increase skin irritation. Many clinicians advise applying the retinoid at night and azelaic acid in the morning, or alternating days, to minimise discomfort.
Most patients notice a reduction in redness and acne lesions after 4-6 weeks of consistent use, although full benefits may require up to 12 weeks, especially for hyperpigmentation.
Safety in pregnancy has not been fully established. The MHRA does not list azelaic acid as contraindicated, but it is classified as a prescription-only product, and use should only be considered if the potential benefit outweighs any possible risk.
Azelaic acid’s tyrosinase-inhibiting property can improve melasma and post-inflammatory hyperpigmentation, but this use is off-label for Azelex. A dermatologist can assess suitability and may recommend a different formulation or concentration.
Azelex is supplied in an opaque, white-to-cream coloured tube with a flip-top cap. The label indicates “20 % azelaic acid gel” and includes dosage instructions and the MHRA registration number.
When applied only to the skin, azelaic acid does not typically affect hair colour. Accidental contact with hair may cause mild lightening, which usually resolves with regular washing.
Topical azelaic acid does not interfere with standard blood or urine tests. However, if you are undergoing dermatological laser procedures, inform the practitioner that you are using azelaic acid.
No. In the United Kingdom, Azelex is a prescription-only medication regulated by the MHRA and must be obtained through a qualified healthcare professional.
Start with a very thin layer once every other day, allowing the skin to adapt. If tolerable, gradually increase to daily use. Always follow up with a gentle, fragrance-free moisturizer and sunscreen.
Yes, but keep the tube in its original packaging with the prescription label visible. When flying, carry it in hand luggage to avoid loss, and be aware that some countries may require a prescription copy for customs.
Azelex is a skin-care product that contains azelaic acid as its active ingredient. It is supplied in a 20 % tube formulation and is classified within the skin-care therapeutic group. In the United Kingdom, Azelex is regulated by the Medicines and Healthcare products Regulatory Agency (MHRA) and is typically prescribed for the treatment of acne vulgaris and rosacea.
The product’s primary purpose is to improve the appearance of inflamed or blemished skin by addressing several underlying processes that contribute to acne and facial redness.
Azelaic acid is a naturally occurring dicarboxylic acid that exerts several pharmacological actions relevant to skin health:
These actions begin shortly after the product is applied, with clinical improvement typically observed after several weeks of consistent use. The tube delivers the acid directly to the skin surface, allowing local action without significant systemic absorption.
Azelex is approved in the UK for the following indications:
The product is intended for adult patients and, where appropriate, for adolescents over the age of 12 under medical supervision. It is usually prescribed when first-line therapies such as topical benzoyl peroxide or retinoids are insufficient or poorly tolerated.
Evidence from peer-reviewed studies suggests azelaic acid may be beneficial for:
Off-label use requires medical supervision and individualized risk assessment.
Patients with any of these conditions should discuss alternative therapies with their healthcare provider.
These effects are generally self-limiting and can be mitigated by applying a thin layer and gradually increasing frequency as tolerated.
Azelaic acid is applied topically, so systemic drug interactions are uncommon. However, the following topical combinations may alter safety or efficacy:
Patients should inform their pharmacist or dermatologist of all topical products they are using.
If a dose is missed, apply it as soon as remembered unless it is close to the next scheduled application. Do not double the dose.
Systemic overdose is highly unlikely due to minimal absorption. In the rare event of extensive skin application leading to severe irritation, rinse the area with cool water and seek medical attention.
Abrupt cessation is acceptable, but some patients may experience a transient return of symptoms. If discontinuing after long-term use, a gradual taper (e.g., every other day for one week) can minimise rebound irritation.
Patients should contact their healthcare professional if severe redness, swelling, or signs of infection appear.
This article provides educational information about Azelex and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
